ETENDERS

Contract award notice

Information

Published

Date of dispatch of this notice: 31/05/2023

External Reference: 2023-204076

TED Reference: 2023/S 106-333710

Contract award notice

[NoticeContractAward]

[NoticeContractAwardSub]

[Directive201424]

[Section1]: [Ca]

I.1)

[NameAddressContact]

Teagasc
N/A
Headquarters
Carlow
Oak Park
IE
[Contactpoint]: Louise Kenny
[AddressPhone]: +353 761111007
[AddressEmail]: louise.kenny@teagasc.ie
[Nutscode]:  IE -  IRELAND
[Internets]:
[UrlGeneral]: www.teagasc.ie
[UrlBuyerprofile]: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/1215

I.4)

[CaType]

[MaintypePublicbody]
I.5)

[Mainactivity]

[OtherActivity]:  Agricultural Advice Research and Training Services

[Section2]: [Object]

II.1)

[QuantityScopeContract]

II.1.1)

[TitleContract]

Services under a Clinical Trial
[Fileref]:  C2993
II.1.2)

[CpvMain]

85141000  - 
II.1.3)

[TypeContract]

[Services]
II.1.4)

[DescrShort]

Teagasc invites tenders for the Establishment of a Single-Party Framework Agreement for the provision Services under a Clinical Trial for Co-Diet Study: combatting diet related non-communicable disease through enhanced surveillance. In general, Teagasc are seeking a supplier to carry out study preparation, recruitment and screenings for the trial.
The Trials are to commence in September 2023.
Please see documents enclosed for additional information.
II.1.6)

[LotsInfo]

[DivisionLots]: [No]
II.1.7)

[ValueTotal]

[ValueExclVat]:  640817.00  EUR
II.2)

[Description]

II.2.2)

[CpvAdditional]

85111810  - 
85146000  - 
85148000  - 
II.2.3)

[PlacePerformance]

[Nutscode]:  IE -  IRELAND
II.2.4)

[DescrProcurement]

Teagasc invites tenders for the Establishment of a Single-Party Framework Agreement for the provision Services under a Clinical Trial for Co-Diet Study: combatting diet related non-communicable disease through enhanced surveillance. In general, Teagasc are seeking a supplier to carry out study preparation, recruitment and screenings for the trial.
The Trials are to commence in September 2023.
Please see documents enclosed for additional information.
II.2.5)

[AwardCriteria]

[AwardCriteriaBelow]
[AwardCriterionQuality]  -  [AwardCriterionName]:  Methodology for Delivering the Study  /  [Weighting]:  40%
[AwardCriterionQuality]  -  [AwardCriterionName]:  Capacity, Reliability and Continuity of Supply  /  [Weighting]:  20%
[AwardCriterionQuality]  -  [AwardCriterionName]:  Duration  /  [Weighting]:  10%
[Price]  -  [Weighting]:  30%
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [Yes]
[EuProgrRef]: EU H2020 grant

[Section4]: [Procedure]

IV.1)

[Description]

IV.1.1)

[TypeProcedure]

[ProctypeOpen]
IV.1.3)

[FrameworkContractDpsInfo]

[NoticeInvolvesFramework]
IV.1.8)

[GpaInfo]

[GpaCovered] : [Yes]
IV.2)

[InfoAdmin]

IV.2.1)

[PubPrevious]

[NumberOj]: 2022/S 216-622042

[Section5]: [AwardOfContract]

[ContractNumber]: 1

[TitleContract]: Services under a Clinical Trial

[AwardConfirm]: [Yes]
V.2)

[AwardOfContract]

V.2.1)

[DateAward]

31/03/2023
V.2.2)

[AwardOffersInfo]

[OffersReceived]:  2
[NumberTendersSme]:  2
[NumberTendersMs]:  0
[NumberTendersNonms]:  0
[OffersReceivedElectronic]:  2
[AwardedGroup] :  [No]
V.2.3)

[AwardedToName]

Atlantia Clinical Trials
Cork
IE
[Nutscode]:  IE -  IRELAND

[AwardedSme] : [Yes]
V.2.4)

[ValueContractInfo] ([ExclVat])

[ValueTotalFinal]:  640817.00  EUR

[Section6]: [InfoComplement]

VI.4)

[AppealsProcedure]

VI.4.1)

[AppealsBody]

High Court
Dublin 7
IE